Table 2.

Characteristics of RA -patients identified in the Swedish Rheumatology Quality Register (SRQ), at baseline, 3-month and 6-month follow-up visit*

	Patients with complete information at 3-month follow-up visit (n=4 831)		Patients with complete information at 6-month follow-up visit (n=4 010)
	Baseline	3-Month follow-up	Baseline	6-Month follow-up
Methotrexate	4 831 (100)	4 497 (93)	4 010 (100)	3 579 (89)
Prednisolone	3 144 (65)	2 984 (62)	2 604 (65)	2 311 (58)
Response status†
Non-responders		1 382 (29)		1 576 (39)
Moderate responders		1 284 (27)		776 (19)
Good responders		2 165 (45)		1 658 (41)

*Values are the number (%).

†Response status according to EULAR response criteria. If change of DMARD at follow-up visit=non-responder.

RA, rheumatoid arthritis.